Navigation Links
Bench to bassinet program seeks congenital heart disease treatments

What: To help speed the translation of scientific discoveries into usable treatments in congenital heart disease, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health launched the Bench to Bassinet Program ( This program, which involves several major research institutions across the country, will be highlighted in the March 23 edition of the Journal of the American College of Cardiology. Congenital heart disease affects the lives of 40,000 newborns a year in the United States, and up to 2 million adults are living with congenital heart disease.

The Bench to Bassinet Program consists of three major research efforts. The two newest, highlighted in the journal article, are the Pediatric Cardiac Genomic Consortium and the Cardiovascular Development Consortium. The Bench to Bassinet Program also coordinates with the NHLBI-funded Pediatric Heart Network (, a group of academic institutions in the United States and Canada conducting research to determine optimal therapies for children with congenital and acquired heart disease. New England Research Institutes serves as the coordinating center for the overall program.

Investigators in the Pediatric Cardiac Genomics Consortium will search the human genome for genetic defects that lead to heart problems. The participating research centers will study genetic data from hundreds of individuals born with congenital heart disease to uncover genes that may cause congenital heart disease, and how those genes influence the outcome of therapy. The institutes conducting this research are: The Children's Hospital Boston and the Brigham and Women's Hospital, Mass.; The Children's Hospital of Philadelphia, Pa. ; Columbia University Health Science, New York City; the Mount Sinai School of Medicine, New York City; and Yale University, New Haven, Conn.

Researchers still have many questions about the various complex pathways that lead to the creation of a healthy heart. Advances in technology and recent research findings make this an opportune time to launch an intensive collaboration designed to provide a comprehensive picture of the key steps in the development of healthy and abnormal hearts. Teams in the Cardiovascular Development Consortium will offer vital insights into heart development. The research institutes are: the J. David Gladstone Institutes, San Francisco, Calif.; Harvard University Medical School, Boston, Mass; the University of Pittsburgh, Pa.; and the University of Utah, Salt Lake City.

These two new programs, along with the Pediatric Heart Network, provide the framework to move fundamental knowledge rapidly into clinical practice, and to use insights from clinical practice to inform basic and genetic research.


Contact: NHLBI Communications Office
NIH/National Heart, Lung and Blood Institute

Related medicine news :

1. Indian Bollywood Masala Sets New Benchmarks in Blogspot World
2. Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
3. Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
4. Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
5. Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
6. Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
7. Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013
8. Pitt part of $100 million NHLBI Bench to Bassinet effort in congenital heart disease
9. UHC Benchmarking Project Focuses on Patient- and Family-Centered Care in Academic Medical Centers
10. Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports
11. Experts Outline Challenges to Translational Research in the United States at a Capitol Hill Briefing, Emphasizing the Importance of Bringing Medical Innovation from Bench to Bedside
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: